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Abstract
Background: To reduce the duration of sick leave and loss of productivity due to common mental disorders (CMDs),
we developed a return-to-work programme to be provided by occupational physicians (OPs) based on the principles of
exposure in vivo (RTW-E programme). This study evaluates this programme's effectiveness and cost-effectiveness by
comparing it with care as usual (CAU). The three research questions we have are: 1) Is an RTW-E programme more
effective in reducing the sick leave of employees with common mental disorders, compared with care as usual? 2) Is an
RTW-E programme more effective in reducing sick leave for employees with anxiety disorders compared with
employees with other common mental disorders? 3) From a societal perspective, is an RTW-E programme cost-effective
compared with care as usual?
Methods/design: This study was designed as a pragmatic cluster-randomized controlled trial with a one-year follow-up
and randomization on the level of OPs. We aimed for 60 OPs in order to include 200 patients. Patients in the intervention
group received the RTW-E programme. Patients in the control group received care as usual. Eligible patients had been
on sick leave due to common mental disorders for at least two weeks and no longer than eight weeks. As primary
outcome measures, we calculated the time until full return to work and the duration of sick leave. Secondary outcome
measures were time until partial return to work, prevalence rate of sick leave at 3, 6, 9, and 12 months' follow-up, and
scores of symptoms of distress, anxiety, depression, somatization, and fatigue; work capacity; perceived working
conditions; self-efficacy for return to work; coping behaviour; avoidance behaviour; patient satisfaction; and work
adaptations. As process measures, we used indices of compliance with the intervention in the intervention group and
employee-supervisor communication in both groups. Economic costs were calculated from a societal perspective. The
total costs consisted of the costs of consuming health care, costs of production loss due to sick leave and reduced
productivity, and out-of-pocket costs of patients for travelling to their OP.
Discussion: The results will be published in 2009. The strengths and weaknesses of the study protocol are discussed.
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Background
Common mental disorders and the effectiveness of 
interventions
Common mental disorders (CMDs) are described as mild
to moderately severe mental disorders. However, there is
no generally accepted definition. Some experts define
CMDs as consisting of depressive, anxiety, and somato-
form disorders based on DSM IV criteria [1]. Others define
CMDs as having a depressive episode or one of four differ-
ent anxiety disorders defined by ICD-10, including mixed
anxiety and depressive disorder with sub-threshold symp-
toms [2], or define CMDs as ranging from stress symp-
toms, measured by for instance the General Health
Questionnaire, to minor usually mixed anxiety and
depressive symptoms as often seen in primary care [3]. We
defined CMDs as a broad concept including stress-related
disorders and depressive, anxiety, and adjustment disor-
ders based on DSM IV criteria.
The working population prevalence rates of anxiety,
depressive disorders, and stress-related disorders are high.
Sanderson et al. [4] showed in a review that the working
population prevalence rates vary by region. They found
prevalence rates of depressive disorders varying from
2.2% in Australia to 4.8% in the Netherlands. Also, the
prevalence rates of various anxiety disorders vary, such as
from 0.1% in Australia to 1.8% in the US for agoraphobia,
and from 5.2% in the US to 5.6% in the Netherlands for
simple phobia. The prevalence rates of stress-related disor-
ders, measured by the General Health Questionnaire
(GHQ) or Maslach Burnout Inventory (MBI-GS) vary
from 35% in the UK [3] to 27% in Finland [5].
The impact of CMDs on personal lives, companies, and
society is substantial. CMDs are associated with personal
costs such as a reduction in the quality of life, role func-
tioning, and income. Furthermore, CMDs are associated
with increased sick leave [2-5] and loss of productivity
[4,6]. At a societal level, the estimated costs due to CMDs
are deemed to be substantial. The annual costs of depres-
sive disorders in the United States were estimated at $83.1
billion in 2000 [7]. A major proportion (62%) of these
costs is due to loss of productivity, sickness absence, and
work disability. Although there is a lack of cost-of-illness
data related to anxiety disorders in Europe [8], some esti-
mates are available from individual countries. The annual
excess costs of prevalent cases of mood and anxiety disor-
ders at population level in the Netherlands are estimated
at 560 million euros [9] per 1 million people aged 18 to
65 years. Of these costs, 85% are due to production loss.
Evaluation studies of clinical treatments for various anxi-
ety and depressive disorders, such as cognitive behav-
ioural therapy (CBT) and pharmacotherapy, showed that
symptoms can be reduced effectively [10-13]. However,
only a limited number of studies measured work-related
outcomes [14] and hardly any studies demonstrated effec-
tiveness in terms of reduced sick leave or increased pro-
ductivity. We may therefore conclude that well-known
evidence-based treatments for depressive and anxiety dis-
orders such as CBT and medication can be effective in
reducing symptoms but do not automatically reduce
absenteeism or improve productivity. In order to achieve
earlier return to work and build up productivity, work-
directed interventions seem promising, especially when
work conditions can be considered as causal factors.
Van der Klink et al. [15] and Schene et al. [16] both con-
ducted a randomized controlled trial (RCT) to evaluate
the effectiveness of a work-directed intervention pro-
gramme with workers on sick leave due to stress-related
and major depressive disorders, respectively. They com-
pared the intervention programme with care as usual. In
both studies, they found a reduced duration of sick leave
of a work-directed intervention programme. The mean
duration of sick leave was reduced by 21 [15] and 92 days
[16], respectively. Moreover, Blonk et al. [17] found, in a
RCT on the effectiveness of an similar work-directed inter-
vention programme for self-employed workers, a reduced
median duration of sick leave of approximately 200 days,
compared with a no treatment and a regular CBT control
group. Furthermore, studies on the effectiveness of similar
but not work-directed intervention programmes [18,19]
showed no reduction of the duration of sick leave. So,
there are indications that work-directed interventions can
reduce sick leave more effectively.
The above-described work-directed interventions [15-17]
combined an activating problem-solving approach to per-
ceived stressors and restoring contact with the working
environment. These ingredients appear to contribute to a
shorter duration of sick leave. For the activating problem-
solving approach, this presumption is supported by the
findings of Van Rhenen et al. [20]. They found, in a large
cohort study of employees with a high stress level, that
employees with an active problem-solving coping strategy
are less likely to drop out because of sickness absence in
terms of frequency, length, and duration of sickness
absence. Moreover, an avoidant coping style was associ-
ated with increased frequency of reporting sickness and
the duration of sick leave.
Restoring contact with the working environment by a
gradual increase in working hours could be another effec-
tive ingredient of work-directed intervention programmes
that contributes to a shorter duration of sick leave, as the
studies described above [15-17] also have this element in
common. In order to increase working hours gradually
during the return to work process and prevent avoidance
of perceived stressors simultaneously, exposure in vivo asBMC Public Health 2009, 9:140 http://www.biomedcentral.com/1471-2458/9/140
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part of a work-directed intervention programme may be
an interesting new approach. During such an exposure in
vivo treatment patients can gradually learn to cope more
actively with stressful work situations.
Exposure in vivo is a well-documented, evidence-based
behavioural treatment for anxiety disorders [21], which
decreases anxiety symptoms and associated avoidance
behaviour [22,23]. Although high quality studies on
work-related effects of exposure in vivo in patients with
anxiety disorders are scarce [24], the available evidence
suggests that exposure in vivo can have neutral or positive
work-related effects on patients with obsessive-compul-
sive disorder (OCD) and posttraumatic stress disorder
(PTSD) [24-30]. Exposure in vivo treatment in only one of
these controlled studies [30] can be considered as being
work-directed. The effectiveness of this intervention indi-
cated a high re-employment rate of PTSD patients, a result
that was also found in another non-controlled study with
PTSD patients [31]. So, exposure in vivo could be an effec-
tive part of a work-directed intervention programme.
However, none of these studies reported the effects on sick
leave.
In order to enhance the return to work of patients on sick
leave due to CMDs, we developed a work-directed inter-
vention programme based on the principles of exposure
in vivo (RTW-E programme). We developed this pro-
gramme for application by OPs in addition to their care as
usual for patients with CMDs. To evaluate the effective-
ness of the programme on sick leave measures, we
planned to compare this programme with care as usual. As
part of this evaluation, we also planned to compare the
effectiveness of the RTW-E programme on sick leave meas-
ures between employees with anxiety disorders and
employees with other CMDs. We consider this evaluation
interesting as exposure in vivo in clinical treatment is an
established treatment in reducing anxiety symptoms. In
addition, we planned to evaluate the cost-effectiveness of
the RTW-E programme compared with care as usual
(CAU), from a societal perspective.
In the designed study, we therefore hypothesized:
- that an RTW-E programme is more effective in reduc-
ing the sick leave of employees with CMDs compared
with CAU
- that an RTW-E programme is more effective in reduc-
ing sick leave for employees with anxiety disorders
compared with employees with other CMDs
- that, from a societal perspective, an RTW-E pro-
gramme is cost-effective compared with care as usual.
Methods/design
To describe the design of the study, all the items of the
CONSORT statement [32], aimed at improving the qual-
ity of reporting of RCTs, will be discussed. To describe the
economic evaluation in this study, we used the guidelines
on presenting studies on health economics [33].
Dutch context
In the Netherlands, most employees on sick leave due to
CMDs visit an occupational physician (OP). Individual
employees and their employers have, according to
national legislation, a shared responsibility for minimiz-
ing health complaints and sick leave. In order to accom-
plish this, the employer is obliged to contract an OP who
is a medical expert as well as an advisor on sick leave for
both the employee and the employer. For the individual
employee and his supervisor, an important task of the OP
is individual counselling in the case of sick leave in order
to support the return to work. In order to structure the
individual counselling of patients with CMDs, Dutch OPs
have developed and implemented professional practice
guidelines [34,35]. A majority of the Dutch OPs have
received training in counselling according to these guide-
lines. Although compliance with these guidelines can be
improved [36], we considered working in accordance with
these guidelines as representative of care as usual (CAU)
in the Netherlands.
Study design
The study was designed as a two-armed cluster-rand-
omized trial (RCT) with randomization on the level of
OPs. OPs from various occupational health services
agreed to participate in the study. The OPs in the control
group counselled their patients according to CAU and the
OPs in the intervention group counselled their patients
according to the RTW-E programme. After inclusion and
baseline measurement, measurement took place every
three months from the first day of sick leave for a period
of twelve months. In the intervention group, compliance
with the RTW-E programme was monitored during fol-
low-up. Sick leave was monitored continuously until full
return to work was achieved. Recurrences of sick leave
were measured every three months.
Patients were blinded to the intervention, as OPs were
instructed not to inform patients about the content of
their counselling. Blinding OPs to the intervention was
not feasible as every OP was trained to apply either the
experimental intervention (counselling according to the
RTW-E programme) or CAU. Therefore, all the OPs knew
which type of intervention they conducted. To prevent
contamination between the two groups, the OPs in the
control group were neither informed about nor received
training in the RTW-E programme. The OPs in the inter-
vention group were requested not to disclose the newBMC Public Health 2009, 9:140 http://www.biomedcentral.com/1471-2458/9/140
Page 4 of 11
(page number not for citation purposes)
intervention during the inclusion period to OPs in the
control group. Furthermore, the chance of contamination
was small as almost every OP in the study worked at a geo-
graphically different worksite.
The design we used is presented in Figure 1.
The Medical Ethics Committee of the Academic Medical
Center and University of Amsterdam approved the study
design, research protocol, information brochure, and
informed consent. Patients voluntarily participated in the
study. A written informed consent was obtained from
each patient. Patients were informed about their right to
withdraw from the study at any time, without specifica-
tion of reasons and with no negative consequences for
their treatment. Patients who withdrew received care as
usual. The acronym we used for the study is 'WORK UP
study'.
Sample size and randomization
In this study, we wanted to include 60 OPs who would in
turn include 200 patients in order to be able to detect a
statistically significant difference in sick leave between
groups. This sample size was not based on a power analy-
sis as software for such an analysis of survival data was not
available at the time. In a comparable intervention study
of Van der Klink et al. [15], significant differences were
found with 33 OPs (17 in the experimental and 16 in the
control group) and 192 patients (109 experimental and
83 control group). In that study, each OP included an
average of 6 patients (range 1–16).
After randomization, we expected the experimental and
control groups each to consist of 30 OPs, who were
expected to include 3 or 4 patients each. To realize the
inclusion of 200 patients, we requested every OP to
include 8 patients as we expected a high drop-out rate of
OPs e.g. caused by a dynamic labour market.
OPs presented themselves for participation in the study.
All the presented OPs were randomized to the experimen-
tal or control group. We performed a restricted randomi-
zation with blocks of four OPs. Every time four OPs
presented themselves to researcher EN, these were rand-
omized by researcher KN, concealed from researcher EN.
After randomization, researcher KN informed EN about
Design of the study Figure 1
Design of the study.
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the allocation of every OP and saved the randomization
file. If an OP in the control group dropped out within a
month of randomization, we reused the attributed
number of randomization. If an OP in the experimental
group dropped out before being trained in the RTW-E pro-
gramme, we reused the attributed number of randomiza-
tion, as we wanted to prevent skewness in the distribution
between the experimental and control groups as much as
possible.
Recruitment of occupational physicians
Participating OPs were recruited from May 2006 until
August 2006 from various occupational health services
geographically widespread over the Netherlands. The OPs
were invited by a written letter accompanied by an infor-
mation brochure in which the purpose, the demands, and
the gains of the study were explained. After inclusion, the
control group was offered a one-day training in the RTW-
E programme if they had included the requested eight
patients. For attending the training and each tutorial ses-
sion, OPs received educational credits recognized by the
National Association of Occupational Medicine. Before
randomization, the OPs were committed to presenting
eight patients for inclusion by signing an agreement. In
addition, every OP received a seven-item questionnaire
concerning personal (one item) and professional charac-
teristics (seven items). We also committed the manage-
ment of the occupational health services of participating
OPs to the study by requesting them to sign an agreement
in which they confirmed the feasibility of the study.
Recruitment of patients
Inclusion criteria
We included patients absent from work due to CMDs if
they were on sick leave for at least two weeks and no
longer than eight weeks at the moment of inclusion.
CMDs were defined as stress-related, adjustment, anxiety,
or depressive disorders. Stress-related disorders were clas-
sified according to the guidelines for OPs [34,35]. Anxiety,
depressive, and adjustment disorders were classified by
the Diagnostic Statistical Manual (DSM), version IV. We
included only patients who, at the moment of inclusion,
had not yet fully returned to work.
Exclusion criteria
Patients with a current psychiatric disorder at the moment
of inclusion, such as PTSS, substance-related disorder, or
psychotic disorder as defined by DSM IV classification,
were excluded. Also, patients with a primary somatic dis-
order according to the OP were excluded. Furthermore,
non-Dutch speaking patients were excluded.
Procedure
Patients who met the inclusion criteria according to the
OP were invited to participate in the study. After a verbal
invitation by the OP, patients received a written informa-
tion leaflet about the study. The leaflet described the pur-
pose and demands of the study, and contained an
informed consent form. With the permission of the
patient, the OP sent his name and telephone number to
researcher EN, who contacted every patient by telephone
to ask if they needed more information to decide whether
or not to participate in the study.
If the patients decided to participate, they were requested
to sign a written informed consent form, for participating
in a telephone diagnostic interview of 25 minutes with
researcher EN, to fill in a baseline questionnaire and 4 fol-
low-up questionnaires at 3, 6, 9, and 12 months after
reporting sick leave, respectively. Furthermore, patients
gave informed consent to register daily, on weekly regis-
tration forms, their hours spent working, on sick leave, or
on vacation, until they returned fully to work. After
informed consent, researcher EN conducted a telephone
diagnostic interview as soon as possible in order to check
eligibility for inclusion in the study. Researcher EN
informed the OPs about the inclusion or exclusion of a
patient by sending them an email. If, during the diagnos-
tic interview, patients were found to be suffering from a
'depressive episode', the risk of suicide was assessed using
a protocol. In the case that we found a moderate or high
suicidal risk, EN informed the patient and recommended
the patient to inform their practitioner(s) about this. If the
patient had not informed their practitioner(s) as we
appointed, we informed the practitioner about the risk by
ourselves if the severity of suicidal risk was deemed to be
more important than the informed consent requirement.
After inclusion, the OPs in the intervention group coun-
selled their patients according to the RTW-E programme
and the OPs in the control group counselled their patients
according to the CAU. After the OPs in the intervention
group finished their counselling, they sent a copy of the
filled-in homework assignment forms to researcher EN.
These forms were used as indicators of compliance with
the RTW-E programme.
Intervention
Training OPs in the intervention group
The OPs in the intervention group received a two-day
training in order to apply the RTW-E programme. Thereaf-
ter, three follow-up tutorial sessions were planned during
the inclusion period. During these sessions, difficulties
with applying the RTW-E programme were discussed with
other participating OPs and practical solutions were
exchanged for problems that had arisen. These sessions
were guided by researchers EN or JvdK, or by an external
well-informed psychologist.
Treatment of patients in the intervention group
After two or three weeks of sick leave, patients were
informed about the RTW-E programme by their OP. ApartBMC Public Health 2009, 9:140 http://www.biomedcentral.com/1471-2458/9/140
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from an oral explanation about the rationale, aim, and
procedure of the RTW-E programme, patients received a
written patient information brochure about the pro-
gramme. This information brochure can be downloaded
in Dutch or English from http://www.psychischen
werk.nl. If the patients accepted the rationale and agreed
with the aim and procedure of the RTW-E programme, the
programme started. This means he or she learned to cope
more actively by gradual exposure to work situations that
evoke lower levels of anxiety, stress, or anger, instead of
using avoidance behaviour in the case of a stressful work
situation. This gradual exposure only concerns stressful
work situations that can not be prevented or solved other-
wise and are an intrinsic part of the job. For instance, a
nurse who is anxious about injecting patients could start
her exposure by watching a colleague who is injecting a
patient, i.e. being exposed to a similar situation but with
a lower level of perceived stress.
The patient is motivated and counselled by the OP in
order to prepare, draw up, and evaluate an exposure-
based RTW plan. This process is structured by giving
patients several 'homework' assignments. The homework
assignments and accompanying forms A to F support the
patient to think about and describe:
a. the time he usually spends on different tasks in his
job and the current feasibility of performing these
tasks (form A),
b. a list of stressful work situations that are relevant to
returning to work, the extent to which these work sit-
uations can be influenced, and how much he tends to
avoid these work situations if they could not be pre-
vented or solved otherwise (form B). The OP supports
the patient in deciding which alternative (active) cop-
ing behaviour, instead of avoidance behaviour, will be
more effective in reducing his negative feelings in the
long term. Applying this alternative coping behaviour
in the stressful work situation will serve as a goal in the
RTW-E programme,
c. various work situations that are similar to the stress-
ful work situation but with lower levels of perceived
stress. After describing such similar work situations in
as much detail as possible, the patient is invited to
rank those work situations according to their per-
ceived stressfulness. The result is called a stress hierar-
chy, in analogy to an anxiety hierarchy for anxiety-
evoking situations used in exposure in vivo for anxiety
disorders (form C),
d. realistic and acceptable RTW arrangements in coop-
eration with his supervisor. The RTW arrangements
had to consist of a gradual increase in the amount of
working hours, feasible tasks, and exposure to increas-
ing levels of stress associated with the listed work situ-
ations in form C (form D). By practising the new
coping behaviour in this way and experiencing several
times that he is able to reduce his feelings of stress to
an acceptable level without using avoidance behav-
iour, the patient will become more confident about
his new coping behaviour. The gradual exposure is
part of the return to work plan directly from the start
of reintegration,
e. the evaluation of the RTW arrangements made in
form D, in cooperation with his supervisor (form E),
f. new additional RTW arrangements in cooperation
with his supervisor after evaluating the results of ear-
lier RTW arrangements (form F).
The homework assignment forms A to F can also be down-
loaded in Dutch or English from http://www.psychisch
enwerk.nl.
Training OPs in the control group
We considered the Dutch guidelines on employees with
CMDs [34,35] as care as usual. The OPs in the control
group received a one-day training in order to update their
skills in counselling according to these guidelines.
Treatment of patients in the control group
Patients in the control group received counselling accord-
ing to care as usual (CAU). According to the guidelines,
CMD is defined as a (temporary) lack of control of the
patient in dealing with his demanding private, working,
and health care environment. Therapy and guidance are
aimed at helping the patient regain control and rebuild
his social and occupational contacts and activities [35].
The OP can reach this goal by using recommended meth-
ods such as stress inoculation training, cognitive restruc-
turing, graded activity, and time contingency during
return to work.
CAU meant that patients were informed by their OP about
the CAU, which could be supported by a patient informa-
tion brochure, 'Nervous exhaustion'. This brochure can be
downloaded from http://www.psychischenwerk.nl (in
Dutch). If the patient accepted the rationale of the CAU,
the OP motivated the patient to prepare, draw up, and
evaluate a RTW plan in co-operation with the supervisor.
This RTW plan was based solely on a gradual and time-
contingent increase in the amount of working hours and
feasible tasks. It was not based on gradual exposure in
vivo or on a stress hierarchy of work situations at the
workplace. This RTW plan was also prepared and struc-
tured by giving patients several homework assignmentsBMC Public Health 2009, 9:140 http://www.biomedcentral.com/1471-2458/9/140
Page 7 of 11
(page number not for citation purposes)
aimed at strengthening the problem-solving behaviour of
both the patient and his supervisor.
Measures
Diagnostic interview
We used the Mini-International Neuropsychiatric Inter-
view (MINI plus; Dutch version 5.0.0.) as a diagnostic
interview in order to include or exclude patients [36]. To
include patients, the MINI was administered for the clas-
sification of symptoms of major depression, dysthymia,
panic disorder, agoraphobia, social phobia, simple pho-
bia, obsessive-compulsive disorder, generalized anxiety
disorder, hypochondria, and adjustment disorder accord-
ing to Axis I of DSM IV. Other parts of the MINI were used
to exclude patients. Psychometric properties of the MINI
can be considered as good [37].
Primary outcome
Sick leave
Time until full return to work and the duration of sick
leave were used as primary outcome parameters. The time
until full RTW was calculated as the number of calendar
days from the first day of sick leave to the first day of full
return to work. The duration of sick leave was calculated
as the number of hours of calendar days on sick leave
from the first day of sick leave until full return to work,
lasting at least 28 calendar days without partial or full
relapse.
Secondary outcomes
Sick leave
As secondary measures of sick leave, we calculated the
time until partial return to work and the prevalence rate of
partial and full return to work at 3, 6, 9, and 12 months'
follow-up. The time until partial RTW was calculated in a
similar way to how we calculated time to full RTW. The
prevalence rate was calculated as the number of persons
who (partially or fully) returned to work divided by the
total number of persons in the intervention or control
group at 3, 6, 9, and 12 months' follow-up.
Distress, anxiety, depression, and somatization
We measured distress and somatization symptoms by
using the distress and somatization subscales of the Four-
Dimensional Symptom Questionnaire (4DSQ) [38]. Anx-
iety and depressive symptoms were measured by the anx-
iety and depression subscales of the 4DSQ and the
Hospital Anxiety and Depression Scale (HADS).
The Four-Dimensional Symptom Questionnaire (4DSQ)
is a Dutch self-report questionnaire that consists of 50
items distributed over 4 subscales. The distress subscale
contains 16 items and the total score ranges from 0 to 32,
the depression subscale contains 6 items and the total
score ranges from 0 to 12, the anxiety subscale contains 12
items and the total score ranges from 0 to 24, and the
somatization subscale contains 16 items and the total
score ranges from 0 to 32. Higher scores indicate more dis-
tress, depression, anxiety, or somatization. The 4DSQ
appears to be a valid and reliable self-report questionnaire
for primary care patients. The Cronbach's alpha for the 4
subscales ranged from 0.84 to 0.90 [38].
The Hospital Anxiety and Depression Scale (HADS) is a
14-item self-report screening scale. It contains two 7-item
subscales for anxiety and depression. Both subscale scores
range from 0 to 21 with higher scores indicating more
depression or anxiety. The HADS showed good homoge-
neity and reliability, with Cronbach's alpha for the sub-
scales anxiety and depression ranged from 0.81 to 0.84
and from 0.79 to 0.86, respectively, in different Dutch
samples [39].
Fatigue
We measured fatigue by using the multi-dimensional
Checklist Individual Strength Questionnaire (CIS). CIS
consists of 20 statements distributed over four dimen-
sions: subjective feeling of fatigue (8 items), motivation
(4 items), physical activity (3 items), and concentration
(5 items). Each item is scored for the past 2 weeks on a 7-
point Likert scale ranging from 1 (true) to 7 (not true).
The CIS was able to measure changes in fatigue scores in
groups as well as in individual workers in randomized
controlled trials [40]. Furthermore, the discriminant
validity of the CIS was adequate for employees in occupa-
tional groups [41]. The internal consistency of the CIS was
also good for clinical and working populations, and the
Cronbach's alpha for the total CIS was found to be 0.90
[42] and 0.91 [43], respectively.
Work capacity
We measured current work ability by using a single item
of the Work Ability Index (WAI). We asked the patient to
estimate their current work ability compared with their
lifetime best. The score of this item ranges from 0 (cannot
work at all) to 10 (best ever). The evidence for internal
validity, predictive validity for disability, and test-retest
reliability of the WAI questionnaire in workers was satis-
factory [44,45].
Working conditions
We measured working conditions by using 9 out of the 14
subscales of the VBBA core questionnaire: a self-report
questionnaire on perception and judgement of work. We
used the subscales work pace and workload (11 items),
emotional strain (7 items), decision latitude (8 items),
autonomy (11 items), social support colleagues (11
items) and social support supervisor (11 items), ruminat-
ing (4 items), enjoyment of work (9 items), and job inse-
curity (4 items). The Cronbach's alpha for these scalesBMC Public Health 2009, 9:140 http://www.biomedcentral.com/1471-2458/9/140
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ranged from 0.79 to 0.95, which we considered as good
internal reliability [46]. The construct and concurrent
validity of the VBBA core questionnaire are satisfactory
[46].
Self-efficacy for return to work
We measured 'self-efficacy for return to work' by using a
recently developed questionnaire. Jager [47] found, in a
pilot study of workers on sick leave due to CMDs, a satis-
factory construct validity and good reliability: the Cron-
bach's alpha was 0.94, and test-retest reliability 0.75.
Coping behaviour
We measured coping behaviour by using an adapted ver-
sion of the shortened 19-item version of the original 30-
item Utrecht Coping List (UCL) [48,49]. This self-report
questionnaire was designed to measure the coping behav-
iour people use in stressful situations, life events, or daily
hassles. We adapted the questionnaire so that all the items
were concerned with problems at work. Each item was
rated on a 4-point Likert scale ranging from 1 (never) to 4
(very often). The UCL includes 5 dimensions: (1) active
problem-focusing (5 items), (2) seeking social support (5
items), (3) palliative reaction pattern (4 items), (4) avoid-
ance behaviour (3 items), and (5) expression of emotions
(2 items).
Avoidance behaviour related to work
To explore the concept of avoidance behaviour related to
the return to work, we used two questions: Do you avoid
emotional or stress-evoking work situations? Is your pro-
ductivity negatively affected by this? Each question was
scored on a 4-point Likert scale ranging from 1 (seldom or
never) to 4 (very often).
Patient satisfaction with counselling of OP
We measured patient satisfaction with the counselling of
the occupational physician by using the Patient Satisfac-
tion with Occupational Health Services Questionnaire
(PSOHQ) [50]. The questionnaire consists of 20 items
and 4 subscales concerning 'being taken seriously as a
patient', 'trust and confidentiality', 'expectations', and
'attitude towards occupational health services', respec-
tively. The scales showed sufficient reliability [50].
Work adaptations
We measured work adaptations by using two questions:
(1) have work adaptations been made during the last
three months (yes/no)? and (2) if yes, specify these work
adaptations.
Process measures
Compliance of intervention
We measured the compliance of the counselling process
of OPs and their patients with the RTW-E programme by
scoring the presence and quality of filled-in homework
assignment forms. The presence of filled-in forms A (Task
Inventory) to F (Evaluation of Work Tasks and Practice
Situations) was scored by yes or no. The quality of the
filled-in forms was classified by two researchers (EN and
KN) independently. The quality of each form was rated on
a 3-point Likert scale: 0 = not in accordance with the pur-
pose of the form, 1 = partly in accordance with the pur-
pose of the form, and 2 = in accordance with the purpose
of the form. The total quality score of compliance was
classified for each patient as low (< 3), moderate (3–6), or
high (> 6).
Communication employee-supervisor
We measured communication between the employee and
supervisor by using a two-item questionnaire, derived
from a standardized telephone interview concerning
supervisor behaviour related to return to work [51].
Economic evaluation measures
In order to make a cost-effectiveness analysis, we calcu-
lated the effectiveness of the primary outcomes, the costs,
and the incremental cost-effectiveness ratio (ICER) for
each group. The total cost calculations were made from a
societal perspective as recommended for the evaluation of
health care programmes [33]. This means that costs were
calculated independently of those who bear these costs
and receive benefits.
To calculate the total costs, we measured the costs of con-
suming health care (six items) and the costs of production
loss (seven items) by an adapted version of the Trimbos/
iMTA questionnaire for costs associated with psychiatric
illness [52]. Furthermore, we measured the travelling dis-
tance to visit the OP, to calculate out-of-pocket costs.
Except for the duration of sick leave, the items originate
from the TiC-P questionnaire, which in turn originates
from the Short-Form Health and Labor Questionnaire
(SF-HLQ). We calculated the costs of production loss for
each group by multiplying respectively the mean duration
of sick leave and the mean production loss without sick
leave (three items) with the mean net income from paid
work (one item). The reported net income will be vali-
dated with national data of income related to age and gen-
der. If these data can not be considered valid or the
income data of too many patients are unknown, we will
use national data of average production value per worker
related to age and gender.
To calculate the costs of production loss due to sick leave,
we used the friction-costs method [33]. This method cal-
culates the loss of production until the vacancy because of
sick leave is resolved.
To calculate the costs of production loss without sick
leave, we averaged the costs calculated by the method of
Osterhaus and the costs calculated by the HLQ method, asBMC Public Health 2009, 9:140 http://www.biomedcentral.com/1471-2458/9/140
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there is a lack of a golden standard. These two methods
give an overestimation and underestimation of the real
costs, respectively. In the Osterhaus method, production
loss is based on the number of days working with hin-
drance because of health complaints and an estimation of
the efficiency during those days. In the HLQ method, pro-
duction loss is based on the number of hours one needs
to catch up with the work one was not able to do because
of health complaints.
The costs of health care were calculated by multiplying the
number of contacts and visits to health care professionals,
the number of days receiving ambulant or institutional-
ized treatment, and the use of medication, with the prices
of health care according to the guidelines for prices in the
Netherlands [53].
We did not correct for inflation and did not discount costs
as the follow-up period of the study is only one year [33].
All the costs are expressed in euros for the relevant refer-
ence year 2006, 2007, or 2008, the year in which the costs
were generated.
Independent measures
We measured job and personal characteristics and work-
ing conditions at baseline as independent measures. As
job characteristics, we assessed profession, industry,
number of contract hours, type of contract, and years
employed with the employer. As personal characteristics,
we measured age, gender, civil status, and educational
level. As working conditions, we assessed work pace and
workload, emotional strain, decision latitude, autonomy,
social support colleagues and social support supervisor,
ruminating, enjoyment of the work, and job insecurity.
Furthermore, we measured the expected duration of sick
leave, diagnosis, psychological complaints, coping style,
self-efficacy of return to work, and work load at baseline,
as independent measures. We considered all of these
parameters to be potential prognostic factors for the dura-
tion of sick leave.
Statistical analysis
Effect evaluation
The time until full return to work is a primary and the time
until partial return to work a secondary outcome. These
outcomes are based on time-to-event data and therefore a
survival analysis is appropriate. An intention-to-treat
analysis will be performed by means of multilevel analy-
sis, with OPs at the primary hierarchical level and patients
at the secondary hierarchical level. If suitable software for
multilevel analysis is not available, we will use a regular
Cox's multivariate regression analysis to answer the first
and second research questions. We will use the 2 ll likeli-
hood ratio statistical test for testing differences in the out-
come scores between groups. The duration of sick leave
will be analysed by multilevel ANOVA. To test differences
in the prevalence rates, we will use the Mann Whitney U
test.
Except for the time until partial return to work secondary
outcome scores will be analysed by multilevel MANOVA.
Cost-effectiveness evaluation
To test statistically the differences in cost-effectiveness
between groups, we will use the Net Monetary Benefit
(NMB) as a parameter instead of the ICER, as this gives us
the opportunity to test differences in cost-effectiveness
with a regular statistical test. Therefore, we will re-scale the
difference in effect between the two programmes into
monetary value by using the threshold willingness-to-pay
for a unit of effect, and the difference in costs between the
two programmes is subtracted from this value. To test the
differences, we will use the non-parametric bias-corrected
accelerated bootstrapping test. We will also present a cost-
effectiveness plane and an acceptability curve, which
show the probability that the RTW-E programme is more
cost-effective than the CAU. In order to determine the rel-
ative impact of changes in values of different parameters
on the cost-effectiveness calculation, we will perform one-
way and multi-way sensitivity analyses.
Discussion
The results of this study will provide input for evidence-
based treatment options for workers on sick leave due to
common mental complaints. We expected the return-to-
work programme based on the principles of exposure in
vivo (the RTW-E programme) for workers on sick leave
due to common mental complaints to be more effective in
enhancing full return to work compared with care as usual
(CAU). CAU in this study is a rather stringent control con-
dition, as Van der Klink et al. [15] found a reduced dura-
tion of sick leave (21 days) of this intervention related to
the CAU at that time. Nevertheless, we assumed the RTW-
E programme to be robust enough to generate significant
and clinical relevant differences in the duration of sick
leave between groups. Employing a CAU control does
have the benefit of practical relevance. However, such a
control group could have reduced the contrast between
both groups and may have reduced the potential differ-
ence in effect size between groups as a consequence.
Strengths and weaknesses
Strengths
In this field study, we regularly measured outcome – every
three months during a year – which enabled the detection
of relevant changes in clinical status. We used a diagnostic
interview to include or exclude patients, aiming to stand-
ardize the diagnostic process. To calculate the cost-effec-
tiveness, we incorporated, besides losses due to sick leave
and the costs of using health care facilities, also productiv-BMC Public Health 2009, 9:140 http://www.biomedcentral.com/1471-2458/9/140
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ity losses during work (presenteeism). These aspects of the
study increase internal validity.
The external validity of the results of the cost-effectiveness
analysis is improved by the choice of a societal perspective
of the analysis as we can disaggregate the calculated cost-
effectiveness from the societal perspective to other levels,
such as cost-effectiveness for employers [33]. Moreover,
external validity is high as this study can be considered a
pragmatic randomized trial, which means the RTW-E pro-
gramme is evaluated in the context and reality of circum-
stances in which OPs operate daily.
To stimulate compliance with the RTW-E programme, we
offered OPs in the intervention group a two-day training
before inclusion started and three follow-up sessions dur-
ing the inclusion period. The follow-up sessions offered
OPs the opportunity to discuss difficulties and possible
solutions in applying the interventions of the RTW-E pro-
gramme with colleagues. A higher compliance with the
RTW-E programme increases the level to which differ-
ences between groups could be attributed to the RTW-E
programme.
Weaknesses
In this study, we selected patients on sick leave via OPs,
and OPs were randomized instead of patients. Although
this is an efficient way to include patients in the occupa-
tional health field, we may have introduced selection bias
by doing this. Furthermore, OPs were not blinded to the
RTW-E programme as they were trained in the new pro-
gramme. This could also have introduced selection bias.
These aspects of selection bias could possibly exaggerate
the effect size of the study and thereby decrease internal
validity. The OPs could have had a tendency to invite
favourable patients if they reasoned that the RTW-E pro-
gramme was appropriate for them, instead of inviting and
including every patient with a CMD [54].
Although we monitored compliance with the RTW-E pro-
gramme and judged the quality of the filled-in homework
assignment forms, the counselling sessions remained
mainly a black box, as we did not audio- or videotape
treatment sessions and based our judgement of compli-
ance on a list of treatment criteria.
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